Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats
Adrian Julian Marcus,
Igor Iezhitsa,
Renu Agarwal,
Pavel Vassiliev,
Alexander Spasov,
Olga Zhukovskaya,
Vera Anisimova,
Nafeeza Mohd Ismail
Affiliations
Adrian Julian Marcus
Centre for Neuroscience Research, Faculty of Medicine, Universiti Teknologi MARA, Malaysia
Igor Iezhitsa
Centre for Neuroscience Research, Faculty of Medicine, Universiti Teknologi MARA, Malaysia; Volgograd State Medical University, Research Institute of Pharmacology, Volgograd, Russia; Correspondence to: Universiti Teknologi MARA, Faculty of Medicine, Sungai Buloh Campus, Jalan Hospital, 47000 Sungai Buloh, Selangor Darul Ehsan, Malaysia.
Renu Agarwal
Centre for Neuroscience Research, Faculty of Medicine, Universiti Teknologi MARA, Malaysia
Pavel Vassiliev
Volgograd State Medical University, Research Institute of Pharmacology, Volgograd, Russia
Alexander Spasov
Volgograd State Medical University, Research Institute of Pharmacology, Volgograd, Russia
Olga Zhukovskaya
Southern Federal University, Research Institute of Physical and Organic Chemistry, Rostov-on-Don, Russia
Vera Anisimova
Southern Federal University, Research Institute of Physical and Organic Chemistry, Rostov-on-Don, Russia
Nafeeza Mohd Ismail
Centre for Neuroscience Research, Faculty of Medicine, Universiti Teknologi MARA, Malaysia
This data is to document the intraocular pressure (IOP) lowering activity of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats. Effects of single drop application of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on IOP in ocular normotensive rats are presented at 3 different concentrations (0.1%, 0.2% and 0.4%). Time course of changes in IOP is presented over 6 h period post-instillation. The IOP lowering activities of test compounds were determined by assessing maximum decrease in IOP from baseline and corresponding control, duration of IOP lowering and area under curve (AUC) of time versus response curve. Data shown here may serve as benchmarks for other researchers studying IOP-lowering effect of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds and would be useful in determining therapeutic potential of these test compounds as IOP lowering agents. Keywords: Drug screening, Intraocular pressure, Intraocular pressure lowering activity, Imidazo[1,2-a]benzimidazoles, Pyrimido[1,2-a]benzimidazoles, Ocular normotensive rats, Rebound tonometry